sever
acut
respiratori
syndrom
sar
acut
respiratori
diseas
result
infect
previous
undescrib
coronaviru
sarscov
spread
airborn
transmiss
rapid
transmiss
high
infect
unpredict
clinic
progress
fatal
ratio
approxim
made
sar
global
threat
howev
pathogenesi
infecti
agent
still
fulli
understood
asymptomat
mildli
symptomat
sarscov
infect
repres
sarscov
infect
report
mani
place
includ
hong
kong
taiwan
guangdong
provinc
china
singapor
clinic
laboratori
investig
shown
host
genet
background
import
factor
determin
suscept
pathogen
sar
infect
demonstr
genet
haplotyp
associ
low
serum
mannosebind
lectin
mbl
also
associ
sar
find
confirm
independ
studi
suscept
gene
includ
chemokin
motif
ligand
interferon
gamma
ifn
oligoadenyl
synthetas
oa
myxoviru
resist
also
report
involv
major
histocompat
complex
class
gene
hla
lsign
gene
still
disput
sever
report
suggest
nucleocapsid
protein
sarscov
express
earli
stage
viral
infect
detect
serum
associ
sever
pulmonari
inflamm
induc
massiv
proinflammatori
cytokin
product
effort
elucid
mechan
human
cellular
protein
interact
nucleocapsid
protein
screen
yeast
twohybrid
assay
laboratori
translat
elong
factor
cytochrom
subfamili
polypeptid
gene
id
genbank
id
ahsg
gene
id
genbank
id
found
interact
nucleocapsid
protein
sarscov
unpublish
data
ahsg
requir
macrophag
deactiv
endogen
cation
low
serum
ahsg
level
may
caus
uncontrol
product
proinflammatori
cytokin
mice
defici
ahsg
show
hypersensit
lpsinduc
inflamm
cytochrom
famili
inactiv
potent
inflammatori
factor
leukotrien
human
neutrophil
liver
like
major
determin
factor
tissu
damag
amplifi
inflammatori
reaction
recruit
leukocyt
induc
degranul
make
remov
excess
import
prevent
immunolog
damag
consid
ahsg
involv
innat
immun
inflammatori
process
investig
whether
singlenucleotid
polymorph
snp
gene
associ
suscept
viral
infect
previous
note
yeast
twohybrid
analysi
sarscov
nucleocapsid
protein
associ
ahsg
data
shown
substanti
interact
sarscov
n
ahsg
human
serum
incub
gst
gstn
fusion
protein
adsorb
analyz
immunoblot
antiahsg
antibodi
demonstr
ahsg
bind
gstn
gst
figur
obtain
peripher
blood
serum
sampl
sar
patient
diagnos
standard
two
differ
citi
china
sar
patient
eighth
peopl
hospit
southern
china
citi
guangzhou
xiaotangshan
hospit
hospit
temporarili
set
fight
sar
beij
china
ditan
hospit
beij
china
sar
sampl
collect
sar
epidem
analysi
elisa
ifa
confirm
sar
patient
seroposit
antisar
antibodi
specif
elisa
assay
higher
comparison
obtain
two
group
control
sampl
guangzhou
peopl
beij
peopl
guangzhou
control
sampl
collect
sar
epidem
beij
control
sampl
collect
epidem
sampl
collect
peopl
never
develop
sar
assess
influenc
exposur
blood
sampl
health
care
worker
hcw
work
sar
ward
second
affili
hospit
senyaxian
medic
school
obtain
sampl
hcw
develop
sar
cours
hospit
duti
health
care
worker
free
diseas
dna
extract
sampl
select
case
control
han
chines
select
enough
sampl
perform
three
progress
casecontrol
studi
chisquar
test
carri
evalu
whether
case
control
three
studi
match
found
case
control
beij
well
match
sex
age
femal
case
cohort
guangzhou
nonhcw
popul
hcw
popul
compos
femal
nurs
age
tabl
download
snp
genotyp
data
chbjpt
version
hapmap
databas
built
linkag
disequilibrium
ld
map
ahsg
haploview
softwar
version
pairwis
tag
algorithm
implement
tagger
program
haploview
threshold
use
select
tag
snp
assess
snp
report
affect
ahsg
level
associ
diseas
also
select
final
chose
genotyp
region
region
exon
intron
exon
ahsg
gene
genotyp
statist
result
present
tabl
tabl
domin
addit
model
respect
genotyp
statist
analys
guangzhou
nonhcw
popul
reveal
two
tag
snp
associ
sar
ttat
genotyp
associ
increas
suscept
sar
aa
genotyp
ci
tabl
tabl
ttct
genotyp
associ
increas
possibl
develop
clinic
appar
sar
ci
tabl
tabl
valid
studi
beij
popul
polymorph
significantli
associ
sar
develop
rel
ttat
genotyp
ci
tabl
tabl
beij
guangzhou
sampl
group
homogen
demograph
genet
paramet
han
chines
joint
analysi
perform
combin
analysi
two
studi
domin
model
present
tabl
combin
data
two
cohort
ttat
genotyp
frequenc
control
popul
significantli
higher
frequenc
sar
patient
ci
tabl
tabl
adjust
sex
age
nonsignific
associ
observ
sar
suscept
ci
p
high
linkag
disequilibrium
associ
sar
easili
understood
logist
regress
analysi
appli
adjust
linkag
result
show
associ
sar
develop
ci
p
associ
sar
p
remov
influenc
exposur
factor
sar
infect
risk
case
control
hcw
popul
genotyp
though
pvalu
higher
distribut
differ
genotyp
hcw
case
hcw
control
similar
distribut
nonhcw
case
nonhcw
control
differ
approxim
statist
analysi
genotyp
data
case
hcw
control
confirm
find
ci
tabl
test
deviat
hardyweinberg
equilibrium
case
control
within
cohort
within
overal
studi
popul
found
statist
signific
deviat
equilibrium
snp
base
result
conclud
ttat
genotyp
associ
increas
likelihood
develop
sar
aa
genotyp
associ
protect
sar
ahsg
serum
protein
report
associ
ahsg
polymorph
ahsg
serum
concentr
level
howev
convinc
multivari
analysi
perform
identifi
associ
variant
uncov
potenti
function
chang
associ
ahsg
polymorph
healthi
subject
beij
genotyp
ahsg
serum
concentr
determin
expect
associ
genotyp
ahsg
serum
concentr
tabl
order
averag
ahsg
serum
concentr
follow
consist
associ
differ
serum
level
ahsg
furthermor
stepwis
regress
analysi
clearli
show
independ
contributor
variabl
ahsg
serum
concentr
tabl
result
show
ld
caus
associ
ahsg
serum
concentr
locat
promot
region
ahsg
gene
bp
upstream
transcript
start
site
variou
allel
snp
may
yield
phenotyp
differ
ahsg
transcript
level
report
allel
reduc
bind
affin
transcript
factor
repressor
ahsg
express
observ
alleleassoci
differ
ahsg
promot
transcript
activ
two
differ
cell
line
use
luciferas
assay
sequenc
contain
overrepres
sar
patient
show
significantli
lower
promot
activ
figur
also
built
ld
map
select
five
tag
snp
assess
tabl
tabl
tabl
nonhcw
guangzhou
popul
ggag
genotyp
associ
increas
suscept
sar
ci
howev
result
associ
replic
beij
popul
combin
analysi
two
studi
show
associ
snp
analyz
sar
suscept
interact
ahsg
sarscov
nucleocapsid
protein
identifi
valid
chose
ahsg
candid
gene
subsequ
casecontrol
analys
found
associ
one
snp
ahsg
develop
sar
two
separ
casecontrol
studi
well
combin
analysi
studi
adjust
age
sex
consid
exposur
factor
intercomparison
hcwcontrol
case
valid
associ
observ
sar
diseas
hcwcontrol
work
sar
ward
expos
sarscov
least
much
case
addit
polymorph
locat
promot
ahsg
affect
ahsg
serum
level
alter
transcript
activ
genotyp
confer
protect
sar
aa
associ
higher
ahsg
serum
level
casecontrol
studi
includ
individu
reveal
signific
associ
sar
diseas
specif
individu
aa
genotyp
lower
risk
develop
sar
ttat
genotyp
snp
locat
flank
region
ahsg
posit
within
promot
region
shown
variant
affect
ahsg
serum
level
alter
transcript
activ
snp
ahsg
also
shown
associ
ahsg
serum
level
diseas
affect
ahsg
serum
level
studi
demonstr
domin
factor
affect
ahsg
concentr
ahsg
circul
neg
inflammatori
acutephas
glycoprotein
pathophysiolog
sequenc
infect
mediat
macrophagederiv
proinflammatori
cytokin
current
literatur
suggest
avail
ahsg
macrophag
critic
regul
innat
immun
respons
tissu
injuri
infect
ahsg
requir
macrophag
deactiv
endogen
cation
decreas
level
human
fetuin
observ
patient
acut
lymphocyt
hodgkin
nonhodgkin
lymphoma
rheumatoid
arthriti
acut
alcohol
hepat
trauma
condit
macrophageassoci
fetuin
level
decreas
macrophag
deactiv
endogen
counterregul
may
impair
lead
uncontrol
overproduct
proinflammatori
cytokin
recent
work
show
mice
defici
ahsg
hypersensit
lpsinduc
inflamm
develop
sar
alway
associ
sever
inflammatori
reaction
low
ahsg
serum
level
could
result
sever
symptom
sarscov
infect
consid
might
mani
asymptomat
sarscov
infect
control
group
plausibl
rel
higher
serum
concentr
ahsg
orchestr
unimpair
counterregul
macrophag
deactiv
endogen
proinflammatori
cytokin
therefor
virus
clear
without
sever
inflamm
obviou
symptom
howev
observ
ahsg
interact
sarscov
nucleocapsid
protein
figur
may
induc
massiv
proinflammatori
cytokin
product
upon
infect
ahsg
may
neutral
proinflammatori
effect
sar
nucleocapsid
protein
ahsg
abund
serum
mgml
consid
ahsg
circul
glycoprotein
synthes
human
liver
tissu
nucleocapsid
protein
wrap
membran
protein
sarscov
virion
interact
ahsg
nucleocapsid
protein
less
like
affect
viral
infect
replic
sarscov
knowledg
first
studi
report
associ
ahsg
polymorph
sar
individu
polymorph
contribut
high
concentr
ahsg
may
less
like
develop
sar
find
improv
understand
sar
pathogenesi
provid
genet
basi
sar
prognosi
futur
studi
investig
mechan
ahsgbas
resist
sar
infecti
diseas
written
inform
consent
obtain
particip
guardian
genet
analysi
cover
consent
studi
perform
approv
ethic
committe
hospit
sampl
obtain
also
approv
ethic
committe
chines
nation
human
genom
center
beij
institut
biotechnolog
beij
proteom
research
center
studi
conduct
accord
principl
declar
helsinki
first
casecontrol
studi
perform
evalu
potenti
associ
ahsg
polymorph
sar
second
casecontrol
studi
perform
confirm
find
first
studi
hcw
casecontrol
studi
use
evalu
influenc
exposur
rate
reconfirm
find
posit
associ
snp
associ
ahsg
genotyp
ahsg
serum
concentr
evalu
healthi
beij
han
chines
serum
sampl
sar
patient
diagnos
standard
collect
eighth
peopl
hospit
guangzhou
analysi
enzymelink
immunosorb
assay
elisa
immunofluoresc
assay
ifa
confirm
sar
patient
seroposit
sar
antibodi
specif
elisa
assay
higher
serum
sampl
age
sex
ethnicitymatch
control
collect
healthi
peopl
guangzhou
period
case
control
han
chines
blood
sampl
patient
diagnos
standard
collect
xiaotangshan
hospit
hospit
temporarili
set
fight
sar
beij
china
ditan
hospit
beij
china
sar
epidem
sar
patient
select
confirm
seroposit
enzymelink
immunosorb
assay
elisa
immunofluoresc
assay
ifa
inform
regard
sex
ethnic
statu
age
sar
diagnosi
record
total
age
sex
ethnicitymatch
adult
recruit
control
subject
sar
epidem
none
control
subject
ever
develop
sar
tabl
sampl
infect
patient
xiaotangshan
hospit
control
bprc
beij
proteom
research
center
china
previous
employ
studi
show
associ
homozygos
protect
sar
coronaviru
case
control
han
chines
remain
sampl
sar
patient
collect
ditan
hospit
blood
sampl
obtain
health
care
worker
develop
sar
cours
hospit
duti
health
care
worker
work
sar
ward
remain
free
diseas
hcw
worker
work
sar
ward
second
affili
hospit
senyaxian
medic
school
inform
regard
sex
age
record
hcw
case
control
han
chines
blood
sampl
healthi
beij
chines
collect
hospit
pla
peopl
liber
armi
beij
sera
collect
serum
ahsg
level
assess
elisa
loci
genotyp
describ
peripher
blood
sampl
obtain
guangzhou
hcw
beij
cohort
total
blood
sampl
mix
incub
lysi
buffer
ammonium
chlorid
mm
potassium
bicarbon
mm
edta
subsequ
lymphocyt
obtain
centrifug
serum
sampl
obtain
guangzhou
nonhcw
case
control
genom
dna
peripher
blood
leukocyt
plasma
sampl
extract
use
qiaamp
dna
blood
mini
kit
qiagen
valencia
ca
store
result
dna
quantifi
use
standard
spectrophotometr
read
du
spectrophotomet
beckman
coulter
fullerton
ca
sampl
dilut
final
concentr
ngml
associ
studi
download
snp
genotyp
data
chbjpt
version
hapmap
databas
built
ld
map
two
gene
haploview
softwar
pairwis
tag
algorithm
implement
tagger
program
haploview
threshold
use
select
tag
snp
snp
report
affect
level
associ
diseas
also
select
final
chose
genotyp
region
region
exon
intron
exon
ahsg
gene
gene
snp
three
linkag
disequilibrium
block
chose
region
region
intron
intron
genotyp
genotyp
complet
use
snpstream
ultrahigh
throughput
genotyp
system
beckman
coulter
fullerton
ca
accord
manufactur
instruct
briefli
method
combin
solutionphas
multiplex
singl
nucleotid
extens
sne
solidphas
sort
label
sne
primer
hybrid
chip
contain
array
oligonucleotid
tag
oligonucleotid
posit
neg
control
sne
primer
contain
oligonucleotid
tag
end
sne
reaction
perform
microarray
plate
imag
use
snp
scope
reader
beckman
coulter
fullerton
ca
twocolor
system
allow
detect
snp
compar
signal
two
fluoresc
dye
imag
signal
subsequ
transfer
genotyp
softwar
translat
imag
array
genotyp
call
error
rate
determin
dna
sequenc
appli
biosystem
inc
snp
examin
present
studi
chisquar
test
use
compar
genotyp
frequenc
demograph
distribut
case
control
exact
test
appli
evalu
whether
popul
equilibrium
markov
chain
method
pvalu
less
consid
statist
signific
tag
snp
chosen
pairwis
basi
linkag
disequilibrium
ld
calcul
perform
confid
interv
ci
basi
use
haploview
softwar
fisher
exact
test
multivari
uncondit
logist
regress
use
estim
crude
adjust
odd
ratio
sex
age
categori
odd
ratio
ci
use
measur
strength
associ
genet
risk
associ
studi
addit
domin
model
use
analysi
addit
model
snp
genotyp
separ
three
categori
homozyg
major
allel
genotyp
chosen
refer
group
domin
model
snp
model
dichotom
variabl
homozyg
major
allel
genotyp
refer
group
two
genotyp
combin
one
categori
anova
stepwis
multivari
regress
analys
perform
identifi
snp
associ
ahsg
serum
level
statist
analys
perform
use
sa
version
serum
ahsg
concentr
measur
subject
elisa
briefli
sera
dilut
pipet
well
microtit
plate
whose
surfac
coat
polyclon
antihuman
ahsg
antibodi
r
incub
horseradish
peroxidas
hrp
conjug
polyclon
antihuman
ahsg
antibodi
ad
well
follow
incub
wash
step
absorb
measur
use
autom
plate
reader
nm
concentr
dilut
sera
read
standard
curv
human
ahsg
concentr
experiment
sampl
calcul
sampl
measur
parallel
duplic
intra
interassay
coeffici
variat
statist
analys
done
use
anova
two
report
plasmid
encompass
bp
human
ahsg
promot
gener
pcr
two
genom
dna
sampl
either
use
primer
respect
pcr
product
digest
bglii
hindiii
ligat
promoterprob
vector
promega
contain
firefli
luciferas
gene
report
construct
sequenc
ensur
correct
clone
cell
seed
cell
per
well
respect
plate
transfect
promoterless
control
contain
particular
allel
ahsg
promot
plasmid
promega
cotransfect
normal
control
transfect
carri
triplic
h
postincub
cell
collect
analyz
luciferas
activ
use
dualluciferas
report
assay
system
promega
data
shown
repres
three
independ
experi
perform
triplic
statist
analys
perform
use
student
ttest
gst
pulldown
experi
human
serum
incub
h
purifi
gst
gst
fusion
protein
bound
glutathion
bead
ge
healthcar
littl
chalfont
buckinghamshir
uk
adsorb
wash
lysi
buffer
subject
sdspage
immunoblot
analysi
purifi
ahsg
protein
includ
load
control
